What Jazz Pharmaceuticals plc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 11 | 57 |
| Total trades | 54 | 147 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 147 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Cozadd Bruce C | Director | Sep 01 | Open-market sale · S | −6,000 | $250.13 | −$1.5M | 351,875 |
| Winningham Rick E | Director | Aug 31 | Withheld — tax / exercise cost · F | −14 | $244.64 | −$3.43K | 9,466 |
| Winningham Rick E | Director | Aug 31 | Withheld — tax / exercise cost · F | −1,692 | $241.39 | −$408K | 9,480 |
| Cozadd Bruce C | Director | Aug 31 | Withheld — tax / exercise cost · F | −1,209 | $241.39 | −$292K | 357,875 |
| Cozadd Bruce C | Director | Aug 31 | Withheld — tax / exercise cost · F | −10 | $244.06 | −$2.44K | 359,084 |
| Enright Patrick G | Director | Aug 31 | Withheld — tax / exercise cost · F | −1,692 | $241.39 | −$408K | 21,278 |
| Enright Patrick G | Director | Aug 31 | Withheld — tax / exercise cost · F | −14 | $244.64 | −$3.43K | 22,970 |
| Cook Jennifer E. | Director | Aug 31 | Withheld — tax / exercise cost · F | −1,692 | $241.39 | −$408K | 10,736 |
| Cook Jennifer E. | Director | Aug 31 | Withheld — tax / exercise cost · F | −14 | $244.06 | −$3.42K | 12,428 |
| Hamill Laura | Director | Aug 31 | Withheld — tax / exercise cost · F | −1,692 | $241.39 | −$408K | 6,832 |
| Hamill Laura | Director | Aug 31 | Withheld — tax / exercise cost · F | −14 | $244.06 | −$3.42K | 8,524 |
| Love Ted W | Director | Aug 31 | Withheld — tax / exercise cost · F | −737 | $241.39 | −$178K | 2,389 |
| Love Ted W | Director | Aug 31 | Withheld — tax / exercise cost · F | −6 | $244.06 | −$1.46K | 3,126 |
| Smith Mark Douglas | Director | Aug 31 | Withheld — tax / exercise cost · F | −1,692 | $241.39 | −$408K | 9,579 |
| Smith Mark Douglas | Director | Aug 31 | Withheld — tax / exercise cost · F | −14 | $244.64 | −$3.43K | 11,271 |
| Henderson Mary Elizabeth | SVP, Technical Operations | Aug 31 | Withheld — tax / exercise cost · F | −16 | $244.64 | −$3.91K | 25,242 |
| Henderson Mary Elizabeth | SVP, Technical Operations | Aug 31 | Withheld — tax / exercise cost · F | −2,076 | $241.39 | −$501K | 25,258 |
| McSharry Heather Ann | Director | Aug 31 | Withheld — tax / exercise cost · F | −1,840 | $241.39 | −$444K | 18,199 |
| McSharry Heather Ann | Director | Aug 31 | Withheld — tax / exercise cost · F | −15 | $244.64 | −$3.67K | 20,039 |
| Kennedy Patrick | Director | Aug 31 | Withheld — tax / exercise cost · F | −1,840 | $241.39 | −$444K | 6,452 |
Loading...